Literature DB >> 21928021

Guideline for management and treatment of fetal and congenital hydrocephalus: Center Of Excellence-Fetal and Congenital Hydrocephalus Top 10 Japan Guideline 2011.

Shizuo Oi1, Takayuki Inagaki, Masaki Shinoda, Satoshi Takahashi, Shigeki Ono, Isao Date, Sadahiro Nomura, Tomoru Miwa, Takashi Araki, Susumu Ito, Hisaaki Uchikado, Osamu Takemoto, Reizo Shirane, Hiroshi Nishimoto, Yuzuru Tashiro, Akira Matsumura.   

Abstract

INTRODUCTION: Hydrocephalus does not indicate a single clinical entity, but includes a variety of clinicopathological conditions caused by excessive cerebrospinal fluid (CSF) based on the disturbed circulation. Recent progress in prenatal neuroimagings such as MRI and ultrasound echoencephalography on fetus enables to understand clinicopathological conditions of CSF circulation disorder in conjunction with morphological changes in the central nervous system properly. It has been revealed that the CSF dynamics develop in the theory of evolution from the immature brain, as in the animals with the minor CSF pathway predominance, towards matured adult human brain together with the completion of the major CSF pathway: the "Evolution Theory in CSF Dynamics". Now, we can analyze CSF circulation dynamically and also analyze the flow velocity and direction of CSF movement. CENTER OF EXCELLENCE-FETAL HYDROCEPHALUS TOP 10 JAPAN: Along with this technical improvement, the standards of clinicopathological evaluation of hydrocephalus as well as the classification and concept of hydrocephalus shall undergo a major upgrade. Based on such remarkable improvement in the recent practical diagnostic evaluation of fetal hydrocephalus, it is now required to update the guideline for management and treatment of fetal and congenital hydrocephalus, and a nationwide study group; Center of Excellence-Fetal Hydrocephalus Top 10 Japan, was organized in 2008 in Japan. The retrospective analysis of 333 cases of congenital hydrocephalus indicated a fact that 43% of these cases were diagnosed prenatally, and the majority of cases were treated in these top 10 institutes in Japan. Now, congenital hydrocephalus diagnosed immediately after birth is regarded as to be based on embryonic stage; brain disorder in patients with congenital hydrocephalus should be considered in conjunction with neuronal mature process of embryonic stage. The fact is supported by the current trends in hydrocephalus research represented by "Perspective Classification of Congenital Hydrocephalus" and "Multi-categorical Hydrocephalus Classification". The ultimate goal of hydrocephalus treatment remains achieving arrested hydrocephalus by shunt surgeries. In the future, to achieve arrested hydrocephalus, minimum quantity of CSF to be drained should be elucidated. Consideration for accurate operative indication of ETV along with new neuroendoscopic device development and analysis of CSF circulation is expected in the future. The data in this prospective multicenter analysis in this guideline are credited in Oxford Evidence level 2b (Grade II).

Entities:  

Mesh:

Year:  2011        PMID: 21928021     DOI: 10.1007/s00381-011-1541-7

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  6 in total

1.  Pathophysiology of long-standing overt ventriculomegaly in adults.

Authors:  S Oi; M Shimoda; M Shibata; Y Honda; K Togo; M Shinoda; R Tsugane; O Sato
Journal:  J Neurosurg       Date:  2000-06       Impact factor: 5.115

2.  EXTIRPATION OF THE CHOROID PLEXUS OF THE LATERAL VENTRICLES IN COMMUNICATING HYDROCEPHALUS.

Authors:  W E Dandy
Journal:  Ann Surg       Date:  1918-12       Impact factor: 12.969

Review 3.  Proposal of "evolution theory in cerebrospinal fluid dynamics" and minor pathway hydrocephalus in developing immature brain.

Authors:  Shizuo Oi; Concezio Di Rocco
Journal:  Childs Nerv Syst       Date:  2006-05-10       Impact factor: 1.475

Review 4.  Hydrocephalus research update--controversies in definition and classification of hydrocephalus.

Authors:  Shizuo Oi
Journal:  Neurol Med Chir (Tokyo)       Date:  2010       Impact factor: 1.742

5.  Intrauterine high-resolution magnetic resonance imaging in fetal hydrocephalus and prenatal estimation of postnatal outcomes with "perspective classification".

Authors:  S Oi; Y Honda; M Hidaka; O Sato; S Matsumoto
Journal:  J Neurosurg       Date:  1998-04       Impact factor: 5.115

6.  "Hydrocephalus-parkinsonism complex": progressive hydrocephalus as a factor affecting extrapyramidal tract disorder-an experimental study.

Authors:  Shizuo Oi; Dong Seok Kim; Mitsuru Hidaka
Journal:  Childs Nerv Syst       Date:  2003-11-05       Impact factor: 1.475

  6 in total
  4 in total

1.  Endoscopic third ventriculostomy in children with chronic communicating congenital hydrocephalus: a single-center cohort retrospective analysis.

Authors:  Laura Baeza-Antón; María Isabel Martínez-León; Bienvenido Ros-López; Miguel Ángel Arráez-Sánchez
Journal:  Childs Nerv Syst       Date:  2021-10-08       Impact factor: 1.475

Review 2.  Choroid plexus coagulation for hydrocephalus not due to CSF overproduction: a review.

Authors:  Xianlun Zhu; Concezio Di Rocco
Journal:  Childs Nerv Syst       Date:  2012-11-15       Impact factor: 1.475

3.  Congenital hydrocephalus in the northeast of Brazil: epidemiological aspects, prenatal diagnosis, and treatment.

Authors:  José Roberto Tude Melo; Emília Nunes de Melo; Angela Gomes de Vasconcellos; Pollyana Pacheco
Journal:  Childs Nerv Syst       Date:  2013-04-23       Impact factor: 1.475

4.  The Japan Neurosurgical Database: Statistics Update 2018 and 2019.

Authors:  Koji Iihara; Nobuhito Saito; Michiyasu Suzuki; Isao Date; Yukihiko Fujii; Kiyohiro Houkin; Tooru Inoue; Toru Iwama; Takakazu Kawamata; Phyo Kim; Hiroyuki Kinouchi; Haruhiko Kishima; Eiji Kohmura; Kaoru Kurisu; Keisuke Maruyama; Yuji Matsumaru; Nobuhiro Mikuni; Susumu Miyamoto; Akio Morita; Hiroyuki Nakase; Yoshitaka Narita; Ryo Nishikawa; Kazuhiko Nozaki; Kuniaki Ogasawara; Kenji Ohata; Nobuyuki Sakai; Hiroaki Sakamoto; Yoshiaki Shiokawa; Jun C Takahashi; Keisuke Ueki; Toshihiko Wakabayashi; Koji Yoshimoto; Hajime Arai; Teiji Tominaga
Journal:  Neurol Med Chir (Tokyo)       Date:  2021-11-03       Impact factor: 1.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.